Skip to main content
bioRxiv

A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma

Publication ,  Preprint
Somarelli, J; Rupprecht, G; Altunel, E; Flamant, E; Rao, S; Sivaraj, D; Lazarides, A; Hoskinson, S; Sheth, M; Cheng, S; Kim, SY; Ware, K ...
2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

2020
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Somarelli, J., Rupprecht, G., Altunel, E., Flamant, E., Rao, S., Sivaraj, D., … Hsu, D. (2020). A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. https://doi.org/10.1101/2020.10.19.346387
Somarelli, Jason, Gabrielle Rupprecht, Erdem Altunel, Etienne Flamant, Sneha Rao, Dharshan Sivaraj, Alexander Lazarides, et al. “A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma.” BioRxiv, 2020. https://doi.org/10.1101/2020.10.19.346387.
Somarelli J, Rupprecht G, Altunel E, Flamant E, Rao S, Sivaraj D, et al. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. 2020.
Somarelli, Jason, et al. “A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma.” BioRxiv, 2020. Epmc, doi:10.1101/2020.10.19.346387.
Somarelli J, Rupprecht G, Altunel E, Flamant E, Rao S, Sivaraj D, Lazarides A, Hoskinson S, Sheth M, Cheng S, Kim SY, Ware K, Agarwal A, Cullen M, Selmic L, Everitt J, McCall S, Eward C, Eward W, Hsu D. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma. bioRxiv. 2020.

DOI

Publication Date

2020